Evidence map›Paper›PMID 35967851›Full record

ArticleFrontiers in cellular and infection microbiology2022

Multidrug-resistant

Fengming Ding, Lei Han, Yishu Xue, Iris Tingshiuan Yang, Xinxin Fan, Rong Tang, Chen Zhang, Miao Zhu, Xue Tian, Ping Shao and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Evolution of Resistant Mutants inMicroorganisms · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Fengming DingDepartment of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Lei HanDepartment of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yishu XueDepartment of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Iris Tingshiuan YangDepartment of Microbiology, University of Washington, Seattle, WA, United States.
Xinxin FanDepartment of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Rong TangDepartment of Clinical Laboratory, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen ZhangDepartment of Medicine, Dinfectome Inc., Nanjing, China.
Miao ZhuDepartment of Bioinformatics and System Development, Dinfectome Inc., Nanjing, China.
Xue TianDepartment of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ping ShaoDepartment of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Min ZhangDepartment of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai First People's Hospital · CNShanghai Jiao Tong University · CNUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multidrug-resistant (MDR) Methods: We prospectively evaluated episodes of chronic Results: We analyzed episodes of Conclusions: Our data indicated that MDR

Indexed as

Bacterial ProteinsBronchiectasisDrug Resistance, Multiple, BacterialPseudomonas aeruginosaPseudomonas InfectionsTrans-ActivatorsCystic FibrosisFibrosisHumansMutationQuorum SensingBacterial ProteinsLasR protein, Pseudomonas aeruginosaTrans-Activatorsefflux pumpLasR activitymultidrug resistancenon-cystic fibrosis bronchiectasisPseudomonas aeruginosa

Identifiers

PMID35967851
PMCPMC9363577
OpenAlexW4288033517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.